Literature DB >> 10872839

Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines.

W Shen1, P Proost, B Li, W Gong, Y Le, R Sargeant, P M Murphy, J Van Damme, J M Wang.   

Abstract

FPRL1 is a seven-transmembrane (STM), G-protein coupled receptor which was originally identified as a low affinity receptor for the bacterial chemotactic formyl peptide and a high affinity receptor for the lipid metabolite lipoxin A4. We recently discovered that a number of peptides, including several synthetic domains of the HIV-1 envelope proteins and the serum amyloid A, use FPRL1 to induce migration and calcium mobilization in human monocytes and neutrophils. In this study, we report that a synthetic peptide domain of the V3 region of the HIV-1 envelope gp120, activates the FPRL1 receptor in monocytes and neutrophils. Furthermore, monocytes prestimulated with V3 peptide showed reduced response to several chemokines that use multiple cell receptors. This is associated with a rapid phosphorylation of the chemokine receptor CCR5 on the serine residues. Our study suggests that FPRL1, as a classical chemoattractant receptor, may play an important role in modulating monocyte activation in the presence of multiple stimuli.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872839     DOI: 10.1006/bbrc.2000.2770

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.

Authors:  Yoshitaka Sogawa; Takao Ohyama; Hiroaki Maeda; Kazuki Hirahara
Journal:  Immunology       Date:  2010-10-29       Impact factor: 7.397

Review 2.  Molecular biology for formyl peptide receptors in human diseases.

Authors:  Yongsheng Li; Duyun Ye
Journal:  J Mol Med (Berl)       Date:  2013-02-13       Impact factor: 4.599

3.  fMLP-dependent activation of Akt and ERK1/2 through ROS/Rho A pathways is mediated through restricted activation of the FPRL1 (FPR2) receptor.

Authors:  Wissam H Faour; Hussein Fayyad-Kazan; Nabil El Zein
Journal:  Inflamm Res       Date:  2018-06-19       Impact factor: 4.575

Review 4.  Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.

Authors:  Efthalia Angelopoulou; Christina Piperi
Journal:  Neuromolecular Med       Date:  2019-07-16       Impact factor: 3.843

Review 5.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

6.  Differential transcriptional regulation by human immunodeficiency virus type 1 and gp120 in human astrocytes.

Authors:  D Galey; K Becker; N Haughey; A Kalehua; D Taub; J Woodward; M P Mattson; A Nath
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

7.  Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity.

Authors:  Jennifer H Madenspacher; Kathleen M Azzam; Wanghua Gong; Kymberly M Gowdy; Michael P Vitek; Daniel T Laskowitz; Alan T Remaley; Ji Ming Wang; Michael B Fessler
Journal:  J Biol Chem       Date:  2012-11-01       Impact factor: 5.157

8.  Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype.

Authors:  R Nedellec; M Coetzer; N Shimizu; H Hoshino; V R Polonis; L Morris; U E A Mårtensson; J Binley; J Overbaugh; D E Mosier
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

Review 9.  Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists.

Authors:  Fabio Cattaneo; Melania Parisi; Rosario Ammendola
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

10.  CCR5 is a suppressor for cortical plasticity and hippocampal learning and memory.

Authors:  Miou Zhou; Stuart Greenhill; Shan Huang; Tawnie K Silva; Yoshitake Sano; Shumin Wu; Ying Cai; Yoshiko Nagaoka; Megha Sehgal; Denise J Cai; Yong-Seok Lee; Kevin Fox; Alcino J Silva
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.